▶ 調査レポート

バイオインフォマティクスの世界市場:技術別(プラットフォーム、ツール、サービス)、用途別(微生物ゲノム、遺伝子工学、薬剤開発、オーダーメイド医療、オミクス、その他)、エンドユーザー別、地域別分析

• 英文タイトル:Global Bioinformatics Market - Segmented by Technology, Applications, End-user and Geography - Growth, Trends and Forecasts (2018 - 2023)

Mordor Intelligenceが調査・発行した産業分析レポートです。バイオインフォマティクスの世界市場:技術別(プラットフォーム、ツール、サービス)、用途別(微生物ゲノム、遺伝子工学、薬剤開発、オーダーメイド医療、オミクス、その他)、エンドユーザー別、地域別分析 / Global Bioinformatics Market - Segmented by Technology, Applications, End-user and Geography - Growth, Trends and Forecasts (2018 - 2023) / B-MOR-040825資料のイメージです。• レポートコード:B-MOR-040825
• 出版社/出版日:Mordor Intelligence / 2018年2月
• レポート形態:英文、PDF、110ページ
• 納品方法:Eメール(受注後2営業日)
• 産業分類:医療・バイオ
• 販売価格(消費税別)
  Single User(1名様用)¥484,500 (USD4,250)▷ お問い合わせ
  Team User(7名様用)¥513,000 (USD4,500)▷ お問い合わせ
  Corporate User¥997,500 (USD8,750)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、バイオインフォマティクスの世界市場について調べ、バイオインフォマティクスの世界規模、市場動向、市場環境、技術別(プラットフォーム、ツール、サービス)分析、用途別(微生物ゲノム、遺伝子工学、薬剤開発、オーダーメイド医療、オミクス、その他)分析、エンドユーザー別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。
・イントロダクション
・エグゼクティブサマリー
・バイオインフォマティクスの世界市場インサイト
・バイオインフォマティクスの世界市場環境
・バイオインフォマティクスの世界市場動向
・バイオインフォマティクスの世界市場規模
・バイオインフォマティクスの世界市場規模:技術別(プラットフォーム、ツール、サービス)
・バイオインフォマティクスの世界市場規模:用途別(微生物ゲノム、遺伝子工学、薬剤開発、オーダーメイド医療、オミクス、その他)
・バイオインフォマティクスの世界市場規模:エンドユーザー別
・バイオインフォマティクスの世界市場:地域別市場規模・分析
・バイオインフォマティクスの北米市場規模・予測
・バイオインフォマティクスのアメリカ市場規模・予測
・バイオインフォマティクスのヨーロッパ市場規模・予測
・バイオインフォマティクスのアジア市場規模・予測
・バイオインフォマティクスの日本市場規模・予測
・バイオインフォマティクスの中国市場規模・予測
・バイオインフォマティクスのインド市場規模・予測
・バイオインフォマティクスの韓国市場規模・予測
・関連企業情報・競争状況

Bioinformatics is the application of computational technology to gather, store, analyze, and integrate biological data. This data is used to procure information that can be applied to gene-based drug discovery and development, protein structure studies, and in order to determine the therapeutic efficacy of drugs. The global bioinformatics market is expected to register a CAGR of 19.8% during 2018-2023 (the forecast period).

Growth in Proteomics and Genomics

With the completion of the Human Genome Project (in 2001) and the Human Proteome Project, a vast amount of data has generated, which has given a new dimension to the profiling of proteomic and genomic analyses. The data generated, out of these projects, has driven the growth of the global bioinformatics market, due to the growing demand for tools and platforms for data management, data retrieval, sequence alignment, structure prediction, and other bioinformatics applications.
Other factors driving the market include increasing government spending and rise in R&D initiatives.

Rising Data Complexity Concerns

A large amount of genomic and proteomic data, generated through various sequencing and structure prediction methods, are highly complex. The complexity of the generated data ranges from missing values to excess unwanted information. Data dissemination has been a major challenge for the growth of the bioinformatics market.
Reimbursement hurdles for the manufacturer and high-capital investment are also restraining the market growth.

North America to Dominate the Market

The bioinformatics market has been segmented on the basis of technology, application, end user, and geography. By geography, the market has been segmented into North America, Europe, Asia-Pacific, the Middle East & Africa, and South America.
Owing to the factors, like the growing demand for bioinformatics across genomics and proteomics research, technological advancements, increasing research funding, and the presence of a large number of market players and research institutes in the region, North America dominates the global bioinformatics market.

Key Developments in the Market

• January 2018: Thermo Fisher Scientific introduced Ion GeneStudio S5 Series, a line of highly versatile next generation sequencers.
• November 2017: Biomillenia collaborated with QIAGEN for the use of QIAGEN’s Microbial Genomics Pro Suite, in order to generate next-generation sequence data on microbes identified using Biomillenia’s proprietary microbiome-on-a-chip technology.
• August 2016: Agilent Technologies and Eurofins Genomics collaborated to expand SureVector cloning system
• January 2016: PerkinElmer, Inc., has signed a strategic collaboration with Attivio in the launch of a new solution in the PerkinElmer Signals data discovery platform.

Major Players: AGILENT TECHNOLOGIES, AFFYMETRIX, ILLUMINA, QIAGEN, PERKINELMER, ACCELRYS, INC., GENEVA BIOINFORMATICS SA amongst others.

Reasons to Purchase This Report

• Market analysis for the Global Bioinformatics Market, with region-specific assessments and competition analysis on the global and regional scale
• Analyzing various market perspectives, with the help of Porter’s five forces analysis
• The treatment type that is expected to dominate the market
• Regions that are expected to witness fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies that are employed by the major market players
• 3 months analyst support, along with the Market Estimate sheet (in excel)

Customization of the Report

• This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.

レポート目次

1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Market Overview
5.3 Porter’s Five Force Analysis
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Degree of Competition
5.3.4 Threat of Substitution
5.3.5 Threat of New Entrants
6. Drivers, Restraints, Opportunities, And Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Rising Government Spending
6.1.2 Increased R&D initiatives
6.1.3 Increase in Growth of Proteomics and Genomics
6.1.4 Increasing Research for Molecular Biology and Drug Discovery
6.1.5 Surge in the Biotechnology Industry in Emerging Countries
6.2 Market Restraints
6.2.1 Lack of Skilled Labor
6.2.2 Lack of Proper Formats
6.2.3 Data Complexity Concerns
6.2.4 Saturation of Pharmaceutical Sector
6.3 Opportunities
6.4 Challenges
7. Market Segmentation
7.1 By Technology
7.1.1 By Platforms
7.1.1.1 Sequence Analysis Platforms
7.1.1.2 Sequence Alignment Platforms
7.1.1.3 Sequence Manipulation Platforms
7.1.1.4 Structural Analysis Platforms
7.1.1.5 Others
7.1.2 By Tool
7.1.2.1 Bioinformatics Content Management Tools
7.1.2.2 Bioinformatics Work-Flow Management Systems
7.1.2.3 Software
7.1.2.4 Web Services
7.1.2.5 Others
7.1.3 By Service
7.1.3.1 Database Management
7.1.3.2 Data Analysis
7.1.3.3 Sequence Services
7.1.3.4 Others
7.2 By Application
7.2.1 Microbial Genome
7.2.2 Gene Engineering
7.2.3 Drug Development
7.2.4 Personalized Medicine
7.2.5 Omics
7.2.6 Others
7.3 By End-Users
7.3.1 Pharmaceuticals
7.3.2 Animal Studies
7.3.3 Agriculture
7.3.4 forensic Science
7.3.5 Academics
7.3.6 Others
7.4 By Geography
7.4.1 North America
7.4.1.1 US
7.4.1.2 Canada
7.4.1.3 Mexico
7.4.2 Europe
7.4.2.1 Germany
7.4.2.2 UK
7.4.2.3 France
7.4.2.4 Italy
7.4.2.5 Spain
7.4.2.6 Rest of Europe (RoE)
7.4.3 Asia Pacific
7.4.3.1 Japan
7.4.3.2 China
7.4.3.3 India
7.4.3.4 South Korea
7.4.3.5 Australia
7.4.3.6 Rest of Asia Pacific
7.4.4 The Middle East & Africa
7.4.4.1 GCC Countries
7.4.4.2 South Africa
7.4.4.3 Rest of Middle East & Africa
7.4.5 South America
7.4.5.1 Brazil
7.4.5.2 Argentina
7.4.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers & Acquisitions
8.2 Agreements, Collaborations & Partnerships
8.3 New Product Launches
9. Key Players
9.1 Agilent Technologies
9.2 Affymetrix
9.3 Illumina
9.4 Qiagen
9.5 Perkinelmer
9.6 Accelrys, Inc.
9.7 Geneva Bioinformatics SA
10. Future of the Market